Journal of Surgery Concepts & Practice ›› 2019, Vol. 24 ›› Issue (05): 400-405.doi: 10.16139/j.1007-9610.2019.05.007
• Experts forum • Previous Articles Next Articles
Received:
2019-07-29
Online:
2019-10-05
Published:
2019-10-05
CLC Number:
[1] Polivka J Jr, Altun I, Golubnitschaja O.Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine[J]. EPMA J,2018,9(1):1-13. [2] Ruiz R, Herrero C, Strasser-Weippl K, et al.Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review[J]. Breast,2017,35:136-141. [3] Royal College of Obstetricians and Gynaecologists. Pregnancy and Breast Cancer, Green-top Guideline[R].[2019-7-29]. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_12.pdf [4] Amant F, Loibl S, Neven P, et al.Breast cancer in pregnancy[J]. Lancet,2012,379(9815):570-579. [5] Genin AS, Lesieur B, Gligorov J, et al.Pregnancy-associa-ted breast cancers: do they differ from other breast cancers in young women[J]. Breast,2012,21(4):550-555. [6] Johansson ALV, Weibull CE, Fredriksson I, et al.Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact[J]. Breast Cancer Res Treat,2019,174(2):489-503. [7] Azim HA Jr, Santoro L, Russell-Edu W, et al.Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies[J]. Cancer Treat Rev,2012,38(7):834-842. [8] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志,2019,29(8):609-680. [9] 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)乳腺癌诊疗指南[M]. 北京:人民卫生出版社,2019:48-56 [10] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology,. Breast Cancer [EB/OL]. Version 1.2019. [2019-7-29]. https://www.nccn.org/patients/default.aspx. [11] Liedtke C, Jackisch C, Thill M, et al.AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer[EB/OL]. [2019-7-29]. https://www.ago-online.de [12] Peccatori FA, Azim HA Jr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up[J]. Ann Oncol,2013,24(Suppl 6):vi160-170. [13] Robbins J, Jeffries D, Roubidoux M, et al.Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation[J]. Am J Roentgenol,2011,196(3):716-722. [14] Tremblay E, Thérasse E, Thomassin-Naggara I, et al.Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation[J]. Radiographics,2012, 32(3):897-911. [15] Cordeiro CN, Gemignani ML.Breast cancer in pregnancy: avoiding fetal harm when maternal treatment is necessary[J]. Breast J,2017,23(2):200-205. [16] Wang PI, Chong ST, Kielar AZ, et al.Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations[J]. Am J Roentgenol,2012,198(4):778-784. [17] Gentilini O, Cremonesi M, Trifirò G, et al.Safety of sentinel node biopsy in pregnant patients with breast cancer[J]. Ann Oncol,2004,15(9):1348-1351. [18] Toesca A, Gentilini O, Peccatori F, et al.Locoregional treatment of breast cancer during pregnancy[J]. Gynecological Surgery,2014,11(4):279-284 [19] Daly MB, Pilarski R, Berry M, et al.NCCN Guidelines insights: Genetic/Familial High-Risk Assessment: Breast and ovarian, Version 2.2017[J]. J Natl Compr Canc Netw,2017,15(1):9-20. [20] Couch FJ, Hart SN, Sharma P, et al.Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer[J]. J Clin Oncol,2015,33(4):304-311. [21] Nancie P, Mary BD, Tuya P.BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer[EB/OL]. [2019-7-29].https://www.ncbi.nlm.nih.gov/books/NBK1247/. [22] Byrski T, Dent R, Blecharz P, et al.Results of a phase Ⅱopen-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer[J]. Breast Cancer Res,2012,14(4):R110. [23] Rosen MA.Management of anesthesia for the pregnant surgical patient[J]. Anesthesiology,1999,91(4):1159-1163. [24] Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary management of breast cancer during pregnancy[J]. Oncologist,2017,22(3):324-334. [25] Lohsiriwat V, Peccatori FA, Martella S, et al.Immediate breast reconstruction with expander in pregnant breast cancer patients[J]. Breast,2013,22(5):657-660. [26] Martin DD.Review of radiation therapy in the pregnant cancer patient[J]. Clin Obstet Gynecol,2011,54(4):591-601. [27] Loibl S, Schmidt A, Gentilini O, et al.Breast cancer dia-gnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients[J]. JAMA Oncol,2015,1(8):1145-1153. [28] Lambertinia M, Di Maio M, Paganic O, et al.The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients[J]. Breast,2018,42:41-49. [29] Cardonick E, Bhat A, Gilmandyar D, et al.Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: Case series and review of the literature[J]. Ann Oncol,2012,23(12):3016-3023. [30] Tutt A, Tovey H, Cheang MCU, et al.Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial[J]. Nat Med,2018, 24(5):628-637. [31] Alsop K, Fereday S, Meldrum C, et al.BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group[J]. J Clin Oncol,2012,30(21):2654-2663. [32] von Minckwitz G, Schneeweiss A, Loibl S, et al. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial[J]. Lancet Oncol,2014,15(7):747-756. [33] Zagouri F, Psaltopoulou T, Dimitrakakis C, et al. Challenges in managing breast cancer during pregnancy[J]. J Thorac Dis,2013,Suppl 1:S62-S67 [34] Goetz O, Burgy C, Langer C, et al.Breastfeeding after breast cancer: survey to hospital health professionals in Alsace[J]. Gynecol Obstet Fertil,2014,42(4):234-239. [35] Litton JK, Theriault RL.Breast cancer and pregnancy: current concepts in diagnosis and treatment[J]. Oncologist,2010,15(12):1238-1247. [36] Stopenski S, Aslam A, Zhang X, et al.After chemotherapy treatment for maternal cancer during pregnancy, is breastfeeding possible?[J]. Breastfeed Med,2017,12:91-97. |
[1] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 385-386. |
[2] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 387-391. |
[3] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 392-395. |
[4] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 396-402. |
[5] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 403-405. |
[6] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 406-410. |
[7] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 411-415. |
[8] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 416-420. |
[9] | YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei. Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 421-428. |
[10] | PAN Ruixin, CHEN Xiaosong, SHEN Kunwei. Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 463-467. |
[11] | ZHU Siyi, CHEN Xiaosong, SHEN Kunwei. Study on obesity associated with prognosis of early breast cancer and efficacy of adjuvant therapy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 468-472. |
[12] | WANG Jieqiang, MA Dekui. Study on trophoblast cell-surface antigen 2 gene and triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 473-477. |
[13] | LIU Miao, SHEN Yan, FU Xiaohong, HU Jiaojiao, CHEN Qingqing, YING Tao. A comparative study on breast cancer between smaller and larger diameters using conventional ultrasound and contrast-enhanced ultrasound [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 229-233. |
[14] | CHEN Yuanyuan, YE Xin, TANG Yongzhe, WANG Jie, HE Qi. Prognosis of invasive micropapillary carcinoma versus invasive ductal carcinoma of the breast: a comparative analysis after propensity score matching [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 353-360. |
[15] | CHEN Xiaosong, LI Shuai, WU Jiayi, HUANG Ou, CHAI Weimin, YAO Jiejie, ZHU Ying, XU Chen, CHEN Jiayi, QU Qing, FEI Xiaochun, DING Xiaoyi, LIN Lin, ZHANG Nan, FANG Qiong, HE Jianrong, ZHU Li, LI Yafen, CHEN Weiguo, SHEN Kunwei. Diagnosis, treatment and survival of breast cancer patients in single large hospital: a 10-year analysis [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 149-158. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||